Duke Cancer Center - Investigational Chemotherapy Service — Durham, North Carolina

Duke Cancer Center - Investigational Chemotherapy Service is a clinical research site located in Durham, North Carolina, United States 27710.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Duke Cancer Center - Investigational Chemotherapy Service has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Intestinal Neoplasms, Gastrointestinal Neoplasms, Digestive System Neoplasms.

Sponsors: Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Durham

Browse all research sites in North Carolina · View every site in Durham

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke Cancer Center - Investigational Chemotherapy Service?

Duke Cancer Center - Investigational Chemotherapy Service has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke Cancer Center - Investigational Chemotherapy Service conducted?

Duke Cancer Center - Investigational Chemotherapy Service has 2 clinical trials on record, with 2 currently active. Their work covers Intestinal Neoplasms, Gastrointestinal Neoplasms, Digestive System Neoplasms.

Is Duke Cancer Center - Investigational Chemotherapy Service accredited by Crixeo Clinical Trials?

Duke Cancer Center - Investigational Chemotherapy Service has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Duke Cancer Center - Investigational Chemotherapy Service?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.